Shandong Weigao Group Medical Polymer Co's market cap is currently HK$23.24B. The company's EPS TTM is HK$0.456; its P/E ratio is 11.26; and it has a dividend yield of 3.97%. Shandong Weigao Group Medical Polymer Co is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is HK$0.25. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 13.23B	¥ 13.62B	¥ 13.15B	¥ 11.35B	¥ 10.36B
Gross Profit	¥ 6.64B	¥ 7.11B	¥ 7.27B	¥ 6.46B	¥ 6.51B
Operating Income	¥ 2.18B	¥ 3.56B	¥ 3.32B	¥ 2.61B	¥ 2.71B
EBITDA	¥ 3.55B	¥ 4.38B	¥ 3.75B	¥ 3.30B	¥ 3.27B
Net Income	¥ 2.00B	¥ 2.76B	¥ 2.28B	¥ 2.09B	¥ 1.84B
Balance Sheet
Cash & Short-Term Investments	¥ 7.33B	¥ 7.36B	¥ 7.06B	¥ 5.98B	¥ 4.66B
Total Assets	¥ 33.67B	¥ 33.20B	¥ 30.37B	¥ 27.34B	¥ 26.33B
Total Debt	¥ 4.17B	¥ 4.49B	¥ 4.14B	¥ 4.32B	¥ 5.52B
Net Debt	¥ -2.82B	¥ -2.37B	¥ -2.49B	¥ -1.19B	¥ 1.28B
Total Liabilities	¥ 9.68B	¥ 9.75B	¥ 9.46B	¥ 8.95B	¥ 9.33B
Stockholders' Equity	¥ 22.45B	¥ 21.67B	¥ 19.27B	¥ 17.55B	¥ 16.19B
Cash Flow
Free Cash Flow	¥ 2.11B	¥ 1.10B	¥ 1.92B	¥ 1.70B	¥ 1.34B
Operating Cash Flow	¥ 2.80B	¥ 2.21B	¥ 3.04B	¥ 2.70B	¥ 2.32B
Investing Cash Flow	¥ -1.39B	¥ -2.57B	¥ -1.48B	¥ 423.22M	¥ -1.34B
Financing Cash Flow	¥ -2.16B	¥ -1.02B	¥ -538.08M	¥ -1.79B	¥ -565.21M

Currency in CNY

Shandong Weigao Group Medical Polymer Co Earnings and Revenue History

Income Statement >

Shandong Weigao Group Medical Polymer Co Debt to Assets

Balance Sheet >

Shandong Weigao Group Medical Polymer Co Cash Flow

Cash Flow >

Shandong Weigao Group Medical Polymer Co Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing